Research paper
Human estrogen receptor messenger RNA variants in both normal and tumor breast tissues

https://doi.org/10.1016/0303-7207(95)03576-SGet rights and content

Abstract

By using the PCR-SSCP technique we characterized various ER-specific RNA species present in a series of primary breast cancers, as well as in cell lines established from breast carcinomas and in mammary gland tissues from healthy specimens. A series of six truncated messenger RNAs generated by alternative splicing was characterized. These RNAs correspond to specific deletions of one (exons 2–7, except exon 6) or two (exons 3 + 4) exons. All these RNA variants are observed in each one of the analyzed RNAs, regardless of origin. In addition, the relative amount of these different variants in ER + tumors is comparable to that measured in ER — tumors and healthy mammary gland tissues. This data suggests that tumor progression is not related to the emergence of any of the ER mRNA variants.

References (38)

  • M. Bouaboula et al.

    J. Biol. Chem.

    (1992)
  • P. Chomczynski et al.

    Anal. Biochem.

    (1987)
  • B.N. Diaz-Chico et al.

    J. Steroid Biochem.

    (1988)
  • S.G.A. Koehorst et al.

    J. Steroid Biochem. Mol. Biol.

    (1993)
  • W.L. McGuire et al.

    J. Steroid Biochem. Mol. Biol.

    (1992)
  • M. Orita et al.

    Genomics

    (1989)
  • P.J. Barrett-Lee et al.

    Cancer Res.

    (1987)
  • A.A.I. Daffada et al.

    J. Mol. Endocrinol.

    (1994)
  • A.A.I. Daffada et al.

    Cancer Res.

    (1995)
  • M. Dean et al.

    Biotechniques

    (1991)
  • H. Dotzlaw et al.

    Mol. Endocrinol.

    (1992)
  • C.A. Encarnacion et al.
  • B.D. Foster et al.

    Cancer Res.

    (1991)
  • S.A.W. Fuqua et al.

    Cancer Res.

    (1991)
  • S.A.W. Fuqua et al.

    Cancer Res.

    (1992)
  • S.A.W. Fuqua et al.

    Breast Cancer Res. Treatment.

    (1993)
  • V. Glisin et al.

    Biochemistry

    (1974)
  • M. Gotteland et al.

    Cancer

    (1994)
  • Cited by (68)

    • The role of estrogen receptor β and nicotinic cholinergic receptors in postpartum depression

      2013, Progress in Neuro-Psychopharmacology and Biological Psychiatry
      Citation Excerpt :

      Human ERβ is approximately 61.2 kB in length and is located on chromosome 14 q23.2 (Kuiper et al., 1996; Mosselman et al., 1996). Initial studies exploring the role of ERβ were in the oncologic sciences, where trophic and developmental functions of estrogen signaling resulted in aberrant cell growth of breast cancer (Gotteland et al., 1995), prostate cancer (Ho et al., 2006), colon cancer (Campbell-Thompson et al., 2001), and ovarian cancer (Anderson et al., 2003), and in which ERβ loss of function seemed to play a critical role (Bardin et al., 2004; Brandenberger et al., 1998; Horvath et al., 2001; Konstantinopoulos et al., 2003). Since that time, roles for ERβ have been described in the development of the central nervous system (Jakab et al., 2001), for protection of the hippocampus (Zhao et al., 2004), in explaining gender disparities in the perception and modulation of pain symptoms (Dao and LeResche, 2000; Leventhal et al., 2006), and as playing a major role in anxiety and mood disorders (Bodo and Rissman, 2006; Imwalle et al., 2005; Walf and Frye, 2007).

    • Oestrogen receptor splice variants in the pathogenesis of disease

      2010, Cancer Letters
      Citation Excerpt :

      Employing a “splice targeted” approach, 20 splice variants of ERα were discovered in breast tumour tissue and various cell lines [44]. Prior to this, several exon-deleted ERα splice variants had been noted in breast tumour cells [63,66,68,69,93–96]. Some of these appear to have an influence on transcriptional activity (see Table 1).

    View all citing articles on Scopus
    View full text